Sanofi’s Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site’s growing business with large pharma ...
California will begin offering its own brand of low-cost insulin in 2026, becoming the first state to contract for and sell an affordable version of the drug to residents, Gov. Gavin Newsom announced ...
Gov. Gavin Newsom announced on Thursday that the first state-made insulin would be available at the start of 2026. California’s CalRx® Insulin Glargine in 3mL pen form will be $55 per five-pack.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback